Base de dados : MEDLINE
Pesquisa : C13.351.500.852.593.150 [Categoria DeCS]
Referências encontradas : 1954 [refinar]
Mostrando: 1 .. 10   no formato [Detalhado]

página 1 de 196 ir para página                         

  1 / 1954 MEDLINE  
              next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28838078
[Au] Autor:Wiesenfeld HC; Manhart LE
[Ad] Endereço:Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, and Magee-Womens Research Institute, Pittsburgh, Pennsylvania.
[Ti] Título:Mycoplasma genitalium in Women: Current Knowledge and Research Priorities for This Recently Emerged Pathogen.
[So] Source:J Infect Dis;216(suppl_2):S389-S395, 2017 Jul 15.
[Is] ISSN:1537-6613
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Health consequences of sexually transmitted diseases disproportionately affect women, making it important to determine whether newly emerged pathogens cause sequelae. Although the pathogenic role of Mycoplasma genitalium in male urethritis is clear, fewer studies have been conducted among women to determine its pathogenic role in the female reproductive tract. Pelvic inflammatory disease (PID) is an important cause of infertility and ectopic pregnancy, and Chlamydia trachomatis and Neisseria gonorrhoeae are recognized microbial causes. Emerging data demonstrate an association between M. genitalium and PID, and limited data suggest associations with infertility and preterm birth, yet the attributable risk for female genital tract infections remains to be defined. Further investigations are needed to better define the impact of M. genitalium on women's reproductive health. Importantly, prospective studies evaluating whether screening programs and targeted treatment of M. genitalium improve reproductive outcomes in women are necessary to guide public health policy for this emerging pathogen.
[Mh] Termos MeSH primário: Infecções por Mycoplasma/complicações
Infecções por Mycoplasma/diagnóstico
Mycoplasma genitalium/isolamento & purificação
Doença Inflamatória Pélvica/microbiologia
Cervicite Uterina/microbiologia
[Mh] Termos MeSH secundário: Feminino
Seres Humanos
Infertilidade Feminina/etiologia
Masculino
Doença Inflamatória Pélvica/complicações
Gravidez
Gravidez Ectópica/etiologia
Nascimento Prematuro/etiologia
Fatores de Risco
Cervicite Uterina/complicações
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW
[Em] Mês de entrada:1709
[Cu] Atualização por classe:170906
[Lr] Data última revisão:
170906
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:170826
[St] Status:MEDLINE
[do] DOI:10.1093/infdis/jix198


  2 / 1954 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28838077
[Au] Autor:McGowin CL; Totten PA
[Ad] Endereço:Departments of 1 Microbiology, Immunology, and Parasitology.
[Ti] Título:The Unique Microbiology and Molecular Pathogenesis of Mycoplasma genitalium.
[So] Source:J Infect Dis;216(suppl_2):S382-S388, 2017 Jul 15.
[Is] ISSN:1537-6613
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Mycoplasma genitalium is increasingly appreciated as a common cause of sexually transmitted disease syndromes, including urethritis in men and cervicitis, endometritis, pelvic inflammatory disease, and possibly preterm birth, tubal factor infertility, and ectopic pregnancy in women. Despite these disease associations, which parallel those of Chlamydia trachomatis and Neisseria gonorrhoeae, the mechanisms by which this pathogen elicits inflammation, causes cellular damage, and persists in its only natural host (humans) are unique and are not fully understood. The purpose of this review is to briefly provide a historical background on the discovery, microbiology, and recognition of M. genitalium as a pathogen, and then summarize the recent advances in our understanding of the molecular biology and pathogenesis of this unique urogenital organism. Collectively, the basic scientific discussions herein should provide a framework for understanding the clinical and epidemiological outcomes described in the accompanying articles in this supplemental issue.
[Mh] Termos MeSH primário: Evasão da Resposta Imune
Infecções por Mycoplasma/imunologia
Mycoplasma genitalium/genética
Mycoplasma genitalium/patogenicidade
Doenças Bacterianas Sexualmente Transmissíveis/imunologia
[Mh] Termos MeSH secundário: Feminino
Genoma Bacteriano
Seres Humanos
Imunidade
Masculino
Mycoplasma genitalium/imunologia
Fatores de Risco
Doenças Bacterianas Sexualmente Transmissíveis/complicações
Uretrite/complicações
Uretrite/microbiologia
Cervicite Uterina/complicações
Cervicite Uterina/microbiologia
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW
[Em] Mês de entrada:1709
[Cu] Atualização por classe:170906
[Lr] Data última revisão:
170906
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:170826
[St] Status:MEDLINE
[do] DOI:10.1093/infdis/jix172


  3 / 1954 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28838072
[Au] Autor:Gaydos CA
[Ad] Endereço:Division of Infectious Diseases, Johns Hopkins University, Baltimore, Maryland.
[Ti] Título:Mycoplasma genitalium: Accurate Diagnosis Is Necessary for Adequate Treatment.
[So] Source:J Infect Dis;216(suppl_2):S406-S411, 2017 Jul 15.
[Is] ISSN:1537-6613
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Background: Mycoplasma genitalium is very difficult to grow in culture but has been more able to be studied for disease associations since the advent of research molecular amplification assays. Polymerase chain reaction (PCR) and other molecular assays have demonstrated an association with adverse disease outcomes, such as urethritis or nongonococcal urethritis in men and adverse reproductive sequelae in women-for example, cervicitis, endometritis, and pelvic inflammatory disease (PID), including an association with risk for human immunodeficiency virus. The lack of commercially available diagnostic assays has limited widespread routine testing. Increasing reports of high rates of resistance to azithromycin detected in research studies have heightened the need available commercial diagnostic assays as well as standardized methods for detecting resistance markers. This review covers available molecular methods for the diagnosis of M. genitalium and assays to predict the antibiotic susceptibility to azithromycin. Methods: A PubMed (US National Library of Medicine and National Institutes of Health) search was conducted for literature published between 2000 and 2016, using the search terms Mycoplasma genitalium, M. genitalium, diagnosis, and detection. Results: Early PCR diagnostic tests focused on the MPa adhesion gene and the 16S ribosomal RNA gene. Subsequently, a transcription-mediated amplification assay targeting ribosomes was developed and widely used to study the epidemiology of M. genitalium. Newer methods have proliferated and include quantitative PCR for organism load, AmpliSens PCR, PCR for the pdhD gene, a PCR-based microarray for multiple sexually transmitted infections, and multiplex PCRs. None yet are cleared by the Food and Drug Administration in the United States, although several assays are CE marked in Europe. As well, many research assays, including PCR, gene sequencing, and melt curve analysis, have been developed to detect the 23S ribosomal RNA gene mutations that confer resistance to azithromycin. One recently developed assay can test for both M. genitalium and azithromycin resistance mutations at the same time. Conclusions: It is recommended that more commercial assays to both diagnose this organism and guide treatment choices should be developed and made available through regulatory approval. Research is needed to establish the cost-effectiveness of routine M. genitalium testing in symptomatic patients and screening in all individuals at high risk of acquiring and transmitting sexually transmitted infections.
[Mh] Termos MeSH primário: Infecções por Mycoplasma/diagnóstico
Mycoplasma genitalium/isolamento & purificação
[Mh] Termos MeSH secundário: Antibacterianos/uso terapêutico
Azitromicina/uso terapêutico
Farmacorresistência Bacteriana
Feminino
Seres Humanos
Macrolídeos/uso terapêutico
Masculino
Reação em Cadeia da Polimerase Multiplex
Mutação
Doença Inflamatória Pélvica/complicações
Doença Inflamatória Pélvica/microbiologia
RNA Ribossômico 16S/genética
Uretrite/complicações
Uretrite/microbiologia
Cervicite Uterina/complicações
Cervicite Uterina/microbiologia
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW
[Nm] Nome de substância:
0 (Anti-Bacterial Agents); 0 (Macrolides); 0 (RNA, Ribosomal, 16S); 83905-01-5 (Azithromycin)
[Em] Mês de entrada:1709
[Cu] Atualização por classe:170906
[Lr] Data última revisão:
170906
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:170826
[St] Status:MEDLINE
[do] DOI:10.1093/infdis/jix104


  4 / 1954 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28445274
[Au] Autor:He Y; Zhao Q; Geng YN; Yang SL; Yin CH; Wu YM
[Ad] Endereço:Department of Gynecological Oncology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Dongcheng District, Beijing, China.
[Ti] Título:Clinical analysis of cervical intraepithelial neoplasia with vaginal intraepithelial neoplasia.
[So] Source:Medicine (Baltimore);96(17):e6700, 2017 Apr.
[Is] ISSN:1536-5964
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:The purpose of this prospective cohort study is to evaluate the importance of screening and its diagnostic accuracy compared with the pathological diagnosis of cervical intraepithelial neoplasia (CIN) with vaginal intraepithelial neoplasia (VAIN).The prospective study enrolled 419 patients (pts) and was conducted between February 1, 2015 and January 31, 2016 at Beijing Obstetrics and Gynecology Hospital, Capital Medical University.All enrolled pts underwent multipoint biopsy of cervix and vaginal wall directed by colposcopy. All samples of biopsy underwent pathological examination. Among them, 201 pts (48.0%) were diagnosed with CIN, 218 pts (52.0%) were diagnosed with cervicitis, and 51 pts (12.2%) were diagnosed with VAIN. It was found that the incidence of CIN in pts was 4 times higher than that of VAIN. In all 419 patients enrolled, 218 pts had cervicitis with 13 pts (6.0%) of VAIN. There were 201 pts of CIN with 38 pts (18.9%) of VAIN: including 53 pts of CIN3 with 12 pts (22.6%) of VAIN; 49 pts of CIN2 with 9 pts of VAIN (18.4%), and 99 pts of CIN1 with 17 pts of VAIN (17.2%). The incidence of CIN with VAIN (18.9%) was significantly higher than cervicitis with VAIN (6.0%) (χ = 16.39, P = .00). Our results showed that there was a significant consistency between cervical lesions and vaginal lesions (χ = 135.91, P = .00), which indicated that the increase of CIN grades may be related to an increase of the VAIN grades. Our results also showed the significant (p < .05) increase of CIN and VAIN with age (<40 years Kappa = 0.04; 40-50 years Kappa = 0.11; >50 years Kappa = 0.28).This study showed that cytological test can be used as a routine screening method for cervical lesions and vaginal diseases. If the cytology result shows abnormality, and pathological examination confirms that there is no obvious abnormal cervical disease, colposcopy directed vaginal multipoint biopsy should be conducted to exclude vaginal disease. All patients of CIN should routinely undergo vaginal multipoint biopsy (1/3 upper vagina), especially in patients with high-grade CIN and age older than 50 years.
[Mh] Termos MeSH primário: Neoplasia Intraepitelial Cervical/diagnóstico
Neoplasia Intraepitelial Cervical/patologia
Neoplasias do Colo do Útero/diagnóstico
Neoplasias do Colo do Útero/patologia
Neoplasias Vaginais/diagnóstico
Neoplasias Vaginais/patologia
[Mh] Termos MeSH secundário: Adulto
Neoplasia Intraepitelial Cervical/complicações
Colposcopia
Detecção Precoce de Câncer
Estudos de Viabilidade
Feminino
Seres Humanos
Biópsia Guiada por Imagem
Meia-Idade
Estadiamento de Neoplasias
Estudos Prospectivos
Neoplasias do Colo do Útero/complicações
Cervicite Uterina/complicações
Neoplasias Vaginais/complicações
[Pt] Tipo de publicação:COMPARATIVE STUDY; EVALUATION STUDIES; JOURNAL ARTICLE
[Em] Mês de entrada:1706
[Cu] Atualização por classe:170601
[Lr] Data última revisão:
170601
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:170427
[St] Status:MEDLINE
[do] DOI:10.1097/MD.0000000000006700


  5 / 1954 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28254220
[Au] Autor:Matsui M; Takahashi Y; Iwagaki S; Chiaki R; Asai K; Kawabata I
[Ad] Endereço:Department of Fetal and Maternal Medicine, Nagara Medical Center, 1300-7 Nagara, Gifu City, Gifu 502-8558, Japan. Electronic address: cu_uchibikuma@mist.ocn.ne.jp.
[Ti] Título:Preliminary preventive protocol from first trimester of pregnancy to reduce preterm birth rate for dichorionic-diamniotic twins.
[So] Source:Taiwan J Obstet Gynecol;56(1):23-26, 2017 Feb.
[Is] ISSN:1875-6263
[Cp] País de publicação:China (Republic : 1949- )
[La] Idioma:eng
[Ab] Resumo:OBJECTIVE: The preterm birth rate of twins is reportedly higher than that of single pregnancies. We performed preliminary preventive interventions at our center focused on evaluating the risk of each case before 14 weeks of gestation to reduce the spontaneous preterm birth rate. MATERIALS AND METHODS: The participants included 184 dichorionic-diamniotic twins delivered at our center during the 8 years from 2006. We evaluated each patient regarding high-risk status (at least 1 additional factor as follows: threatened abortion, history of chorioamnionitis, cervicitis, and bacterial vaginosis), based on available evidence; patients deemed high risk gave their informed consent and underwent treatment for cervicitis and cerclage if indicated. We divided the patients into two groups depending on whether the management was initiated before (Group A) or after (Group B) 14 weeks. We further divided Group A into three: Group 1 underwent treatment for cervicitis, Group 2 underwent cervical cerclage in addition to treatment for cervicitis, and Group 3 did not undergo preventive treatment. We retrospectively compared the preterm birth rates of the two groups, and we also compared them between the higher-risk group (Group 1 + 2) and the no additional risk group (Group 3) in Group A. RESULTS: The spontaneous preterm birth rate < 36 weeks was significantly lower in Group A (4/90; 4.4%) than in Group B (18/94; 19.1%) (p=0.001). However, there were no significant differences between Group 1 + 2 and Group 3 (2/42 vs. 2/46). Focusing on the spontaneous preterm birth rate < 34 weeks, Group A had a lower rate than Group B (2/90; 2.2% vs. 13/94; 13.8%, p=0.0012). CONCLUSION: Even though this was a preliminary study, the results are promising, and we propose custom-made management for dichorionic-diamniotic twins: (1) earlier management from before 14 weeks; (2) high-risk selection for cervicitis and a short cervix; and (3) intervention with anti-inflammatory agents and cerclage if indicated.
[Mh] Termos MeSH primário: Antibacterianos/uso terapêutico
Cerclagem Cervical
Gravidez de Gêmeos
Nascimento Prematuro/prevenção & controle
Cervicite Uterina/terapia
[Mh] Termos MeSH secundário: Adulto
Estudos de Casos e Controles
Feminino
Idade Gestacional
Seres Humanos
Gravidez
Primeiro Trimestre da Gravidez
Estudos Retrospectivos
Gêmeos Dizigóticos
Adulto Jovem
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Anti-Bacterial Agents)
[Em] Mês de entrada:1708
[Cu] Atualização por classe:170825
[Lr] Data última revisão:
170825
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170304
[St] Status:MEDLINE


  6 / 1954 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28246983
[Au] Autor:Liu HL; Chen CM; Pai LW; Hwu YJ; Lee HM; Chung YC
[Ad] Endereço:Department of Nursing, Central Taiwan University of Science and Technology, No. 666, Buzih Road, Beitun District, Taichung, 40601, Taiwan, Republic of China.
[Ti] Título:Comorbidity profiles among women with postcoital bleeding: a nationwide health insurance database.
[So] Source:Arch Gynecol Obstet;295(4):935-941, 2017 Apr.
[Is] ISSN:1432-0711
[Cp] País de publicação:Germany
[La] Idioma:eng
[Ab] Resumo:PURPOSE: Most of the existing studies on postcoital bleeding (PCB) in Western countries. To date, no study has focused on the various PCB-related comorbidities in Taiwan women. This work aims to analyze and compare the presence or absence of PCB among Taiwanese women with gynecological comorbidity. METHODS: This study is a population-based retrospective cohort investigation. Outpatients with PCB after the index date were considered. A total of 2377 female patients with PCB (ICD-9 626.7) were identified using a nationwide outpatient sample from 2001 to 2010. For comparison, 7131 cases were randomly matched with the study group in terms of gender and age. RESULTS: The PCB incidence rate was 39-59 cases/100,000 Taiwanese women, with mean age (±SD) of 36.74 ± 10.79 years, median age of 36 years, and mode age of 29 years. Women with PCB exhibited 1.47-fold risk of cervical dysplasia and 1.59-fold risk for malignant neoplasm of cervix. Young women with PCB showed high risk of cervical cancer. The most common benign diseases among PCB- related comorbidities were cervical erosion and ectropion (20.66%), followed by vaginitis and vulvovaginitis (19.18%). Comparison between PCB and non-PCB groups indicated several significant high-risk comorbidities including cervical polyps, cervical erosion, leukoplakia of cervix, intrauterine contraceptive device, cervicitis, vaginitis, menopause, dyspareunia, and vulvodynia. CONCLUSIONS: This study provides evidence that PCB-related comorbidities manifested benign diseases (51.58%), lower genital tract infection (46.11%), and cervical cancer (2.31%). Thus, healthcare providers must ensure that appropriate routine screening tests and counseling are given to women with PCB.
[Mh] Termos MeSH primário: Disfunções Sexuais Fisiológicas/epidemiologia
[Mh] Termos MeSH secundário: Adulto
Idoso
Neoplasia Intraepitelial Cervical/epidemiologia
Neoplasia Intraepitelial Cervical/patologia
Comorbidade
Feminino
Seres Humanos
Seguro Saúde
Dispositivos Intrauterinos/efeitos adversos
Menopausa
Meia-Idade
Pólipos/epidemiologia
Pólipos/patologia
Infecções do Sistema Genital/epidemiologia
Infecções do Sistema Genital/patologia
Estudos Retrospectivos
Taiwan
Doenças do Colo do Útero/epidemiologia
Doenças do Colo do Útero/patologia
Displasia do Colo do Útero/epidemiologia
Displasia do Colo do Útero/patologia
Neoplasias do Colo do Útero/epidemiologia
Neoplasias do Colo do Útero/patologia
Cervicite Uterina/epidemiologia
Cervicite Uterina/patologia
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1709
[Cu] Atualização por classe:170911
[Lr] Data última revisão:
170911
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170302
[St] Status:MEDLINE
[do] DOI:10.1007/s00404-017-4327-7


  7 / 1954 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:26792283
[Au] Autor:Lusk MJ; Garden FL; Cumming RG; Rawlinson WD; Naing ZW; Konecny P
[Ad] Endereço:1 Short Street Centre, Department of Infectious Diseases, Immunology and Sexual Health, St George Hospital, Kogarah, Sydney, Australia.
[Ti] Título:Cervicitis: a prospective observational study of empiric azithromycin treatment in women with cervicitis and non-specific cervicitis.
[So] Source:Int J STD AIDS;28(2):120-126, 2017 Feb.
[Is] ISSN:1758-1052
[Cp] País de publicação:England
[La] Idioma:eng
[Ab] Resumo:Treatment with 1 G azithromycin was observed prospectively in 130 women with cervicitis (>30 polymorphonuclear leucocytes/high-powered field) enrolled in a cervicitis aetiology study of 558 women at three sexually transmitted infection clinics in Sydney, Australia. Two overlapping groups of women with cervicitis were considered: 'cervicitis group 1' (n = 116) excluded women with Trichomonas vaginalis and a subgroup of this, 'cervicitis group 2' (non-specific cervicitis) (n = 96) further excluded women with Neisseria gonorrhoea, Chlamydia trachomatis and Mycoplasma genitalium at enrolment. Testing for Chlamydia trachomatis, Mycoplasma genitalium and Trichomonas vaginalis was by PCR and Neisseria gonorrhoea by PCR and culture. Treatment outcomes were cervicitis or vaginal symptoms at follow-up. Effect on cervicitis at follow-up was also assessed after additional reported partner treatment. In 'cervicitis group 1' where prevalence of Mycoplasma genitalium and/or Chlamydia trachomatis was 23/116 (19.8%), azithromycin reduced cervicitis at follow-up (RR = 0.62 (95% CI 0.39-0.97) p = 0.035), but there was no significant effect in non-specific cervicitis ('cervicitis group 2') (RR = 0.60 (95% CI 0.35-1.01) p = 0.056). Empiric treatment did not reduce vaginal symptoms at follow-up in either group. No effect of empiric partner treatment was seen. The conclusion was that empiric azithromycin treatment of cervicitis reduces cervicitis at follow-up in populations with high prevalence of Chlamydia trachomatis and/or Mycoplasma genitalium. There are no benefits of empiric azithromycin for non-specific cervicitis or empiric partner treatment.
[Mh] Termos MeSH primário: Azitromicina/uso terapêutico
Cervicite Uterina/tratamento farmacológico
Cervicite Uterina/etiologia
[Mh] Termos MeSH secundário: Adulto
Austrália/epidemiologia
Colo do Útero/patologia
Chlamydia trachomatis
Feminino
Seguimentos
Seres Humanos
Mycoplasma genitalium
Reação em Cadeia da Polimerase
Prevalência
Estudos Prospectivos
Cervicite Uterina/diagnóstico
Cervicite Uterina/epidemiologia
Adulto Jovem
[Pt] Tipo de publicação:JOURNAL ARTICLE; OBSERVATIONAL STUDY
[Nm] Nome de substância:
83905-01-5 (Azithromycin)
[Em] Mês de entrada:1707
[Cu] Atualização por classe:170717
[Lr] Data última revisão:
170717
[Sb] Subgrupo de revista:IM; X
[Da] Data de entrada para processamento:160122
[St] Status:MEDLINE
[do] DOI:10.1177/0956462416628319


  8 / 1954 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
[PMID]:27514125
[Au] Autor:Grueva E; Kovachev E
[Ti] Título:[CHARACTERISTICS OF VAGINAL ECOSYSTEM IN ENDOCERVICITIS CHLAMYDIALIS].
[So] Source:Akush Ginekol (Sofiia);55(1):3-13, 2016.
[Is] ISSN:0324-0959
[Cp] País de publicação:Bulgaria
[La] Idioma:bul
[Ab] Resumo:The study aims: 1. To analyze and study the specifics of microbiocenoses of exocervix at endocervicitis chlamydialis, to differentiate the spectrum of stimuli, and establish the leading role of Chl. trachomatis in the genesis of this process. 2. To determine the leading role of the method of direct (bed-side) microscopy for early and rapid diagnosis of cervicitis and conducting etiotropic therapy. We determined the incidence of endocervicitis chlamydialis, with cause Chl. trachomatis-45.1%, (319 DIF (+) patients out of 708 surveyed), p <0.05, in the Rousse region. Studies indicator presence or absence of vaginal infection, Trichomonas vaginalis, Gardnerella, Candida, Staphiloocus aureus, E. coli, Proteus, Streptoccocus agalactae, the differences between the two samples in terms of the variable was not statistically significant. In our study, in patients with endocervicitis, the incidence of Trichom. vaginalis is 7.0%, Gardnerella-24.4%, Candida-21.4%, Streptococcus agalactae-7.1%, Staphylococcus aureus-6.3%, E. coli-0.4%, Proteus-0.2%. The frequency of Trichomonas vaginalis, npu nauueHmku c endocervicitis chlamydialis e 3.2%, Gardnerella-10.8%, Candida alb. -9.2%, Candida tropicans-0.2% Streptoccocus agalactae-3.3%, Staphyllococus aureus-2.4%, E.coli-0.0%, Proteus-0.0%.The majority of patients with endocervicitis chlamydialis, no other co-infection unless Chl. trachomatis.
[Mh] Termos MeSH primário: Colo do Útero/microbiologia
Infecções por Chlamydia/epidemiologia
Chlamydia trachomatis/isolamento & purificação
Cervicite Uterina/epidemiologia
Cervicite Uterina/microbiologia
Vagina/microbiologia
[Mh] Termos MeSH secundário: Bulgária/epidemiologia
Infecções por Chlamydia/microbiologia
Coinfecção/epidemiologia
Coinfecção/microbiologia
Feminino
Seres Humanos
Vaginite/epidemiologia
Vaginite/microbiologia
[Pt] Tipo de publicação:ENGLISH ABSTRACT; JOURNAL ARTICLE
[Em] Mês de entrada:1609
[Cu] Atualização por classe:160812
[Lr] Data última revisão:
160812
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:160813
[St] Status:MEDLINE


  9 / 1954 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:27331927
[Au] Autor:Oliveto JM; Muinov L
[Ad] Endereço:From the University of Nebraska Medical Center, Omaha, NE.
[Ti] Título:Cystic Cervicitis: A Case Report and Literature Review of Cystic Cervical Lesions.
[So] Source:J Comput Assist Tomogr;40(4):564-6, 2016 Jul-Aug.
[Is] ISSN:1532-3145
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:We present a case of a 30-year-old woman who, while undergoing infertility evaluation, was found to have a large cystic cervical mass, shown to be cystic cervicitis on cervical cone biopsy. Differential diagnosis for benign cystic cervical lesions includes Nabothian cysts, tunnel cluster, endocervical hyperplasia, and cervicitis, whereas cystic cervical malignancies include adenocarcinoma and adenoma malignum. While it is crucial to differentiate benign from malignant lesions, imaging characteristics often overlap and may not provide a specific diagnosis. In difficult cases, definitive diagnosis should be based on clinical presentation and cervical biopsy.
[Mh] Termos MeSH primário: Cistos/diagnóstico por imagem
Cistos/patologia
Neoplasias do Colo do Útero/diagnóstico por imagem
Neoplasias do Colo do Útero/patologia
Cervicite Uterina/diagnóstico por imagem
Cervicite Uterina/patologia
[Mh] Termos MeSH secundário: Adulto
Diagnóstico Diferencial
Feminino
Seres Humanos
Imagem por Ressonância Magnética/métodos
Ultrassonografia/métodos
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE; REVIEW
[Em] Mês de entrada:1701
[Cu] Atualização por classe:170130
[Lr] Data última revisão:
170130
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:160623
[St] Status:MEDLINE
[do] DOI:10.1097/RCT.0000000000000451


  10 / 1954 MEDLINE  
              first record previous record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:27329297
[Au] Autor:Ware CE; Ajabnoor Y; Mullins PM; Mazer-Amirshahi M; Pines JM; May L
[Ad] Endereço:Department of Emergency Medicine, The George Washington University, Washington, DC.
[Ti] Título:A retrospective cross-sectional study of patients treated in US EDs and ambulatory care clinics with sexually transmitted infections from 2001 to 2010.
[So] Source:Am J Emerg Med;34(9):1808-11, 2016 Sep.
[Is] ISSN:1532-8171
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:INTRODUCTION: Sexually transmitted infections (STIs) are commonly seen in the ambulatory health care settings such as emergency departments (EDs) and outpatient clinics. Our objective was to assess trends over time in the incidence and demographics of STIs seen in the ED and outpatient clinics compared with office-based clinics using the National Hospital Ambulatory Medical Care Survey and National Ambulatory Medical Care Survey. METHODS: This study was conducted using 10 years of National Hospital Ambulatory Medical Care Survey and National Ambulatory Medical Care Survey data (2001-2010). We compared data from 2001-2005 to data from 2006-2010. Patients were included in analyses if they were 15 years and older and had an International Classification of Diseases, Ninth Revision code consistent with cervicitis, urethritis, chlamydia, gonorrhea, or trichomonas. RESULTS: We analyzed 82.4 million visits for STIs, with 16.5% seen in hospital-based EDs and 83.5% seen in office-based clinics between 2001 and 2010. Compared with patients seen in office-based clinics, ED patients were younger (P< .05), more likely to be male (P< .001) and nonwhite (P< .001), and less likely to have private insurance (P< .05). We found a significant increase in adolescent (15-18 years) ED visits (P< .05) from 2001-2015 to 2006-2010 and a decrease in adolescent and male STI visits in office-based settings (P< .05). CONCLUSION: Although patients with STI are most commonly seen in office-based clinics, EDs represent an important site of care. In particular, ED patients are relatively younger, male, and nonwhite, and less likely to be private insured.
[Mh] Termos MeSH primário: Assistência Ambulatorial
Infecções por Chlamydia/epidemiologia
Serviço Hospitalar de Emergência
Gonorreia/epidemiologia
Doenças Sexualmente Transmissíveis/epidemiologia
Vaginite por Trichomonas/epidemiologia
Uretrite/epidemiologia
Cervicite Uterina/epidemiologia
[Mh] Termos MeSH secundário: Adolescente
Adulto
Distribuição por Idade
Idoso
Instituições de Assistência Ambulatorial
Estudos Transversais
Feminino
Pesquisas sobre Serviços de Saúde
Seres Humanos
Masculino
Meia-Idade
Estudos Retrospectivos
Distribuição por Sexo
Tricomoníase/epidemiologia
Estados Unidos/epidemiologia
Adulto Jovem
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1703
[Cu] Atualização por classe:170817
[Lr] Data última revisão:
170817
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:160623
[St] Status:MEDLINE



página 1 de 196 ir para página                         
   


Refinar a pesquisa
  Base de dados : MEDLINE Formulário avançado   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/OPAS/OMS - Centro Latino-Americano e do Caribe de Informação em Ciências da Saúde